Impact of β-Lactamase Inhibition on the Activity of Ceftaroline against Mycobacterium tuberculosis and Mycobacterium abscessus

被引：36
|
作者：
Dubee, Vincent [1 ,2 ,3 ,4 ]
Soroka, Daria [1 ,2 ,3 ]
Cortes, Melanie [1 ,2 ,3 ]
Lefebvre, Anne-Laure [1 ,2 ,3 ]
Gutmann, Laurent [1 ,2 ,3 ,5 ]
Hugonnet, Jean-Emmanuel [1 ,2 ,3 ]
Arthur, Michel [1 ,2 ,3 ]
Mainardi, Jean-Luc [1 ,2 ,3 ,5 ]
机构：
[1] INSERM, LRMA, Ctr Rech Cordeliers, Equipe 12,UMR S 1138, Paris, France
[2] Univ Paris 06, Sorbonne Univ, Ctr Rech Cordeliers, UMR S 1138, Paris, France
[3] Univ Paris 05, Ctr Rech Cordeliers, Sorbonne Paris Cite, UMR S 1138, Paris, France
[4] Hop St Antoine, AP HP, Serv Reanimat Med, F-75571 Paris, France
[5] Hop Europeen Georges Pompidou, AP HP, Paris, France
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2015年 / 59卷 / 05期
关键词：
MASSILIENSE; CEPHALOSPORIN; INFECTIONS; ACID;
D O I：
10.1128/AAC.05080-14
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The production of beta-lactamases BlaMab and BlaC contributes to beta-lactam resistance in Mycobacterium abscessus and Mycobacterium tuberculosis, respectively. Ceftaroline was efficiently hydrolyzed by these enzymes. Inhibition of M. tuberculosis BlaC by clavulanate decreased the ceftaroline MIC from >= 256 to 16 to 64 mu g/ml, but these values are clinically irrelevant. In contrast, the ceftaroline-avibactam combination should be evaluated against M. abscessus since it inhibited growth at lower and potentially achievable drug concentrations.
引用
收藏
页码：2938 / 2941
页数：4
相关论文
共 50 条
  • [41] Evaluation of the cross-immunity between Mycobacterium tuberculosis and Mycobacterium abscessus in vitro
    Xu, Da
    Gu, Yujie
    Li, Guilian
    Wang, Ruihuan
    Xiao, Shiqi
    Duan, Hongyang
    Jiang, Jingwei
    Zhao, Xiuqin
    Wan, Kanglin
    He, Xinyue
    Liu, Haican
    Lou, Yongliang
    BMC MICROBIOLOGY, 2025, 25 (01):
  • [42] Who is the criminal? Isolates of Mycobacterium tuberculosis, Mycobacterium abscessus and Mycobacterium gordonae from a patient with pulmonary disease
    Wei, Jianhao
    Jiang, Yi
    Li, Guilian
    Guo, Qian
    Liu, Haican
    Xu, Donglei
    Zheng, Jianghua
    Wan, Kanglin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (07): : 7733 - 7738
  • [43] In Vitro Activity of the New β-Lactamase Inhibitors Relebactam and Vaborbactam in Combination with β-Lactams against Mycobacterium abscessus Complex Clinical Isolates
    Kaushik, Amit
    Ammerman, Nicole C.
    Lee, Jin
    Martins, Olumide
    Kreiswirth, Barry N.
    Lamichhane, Gyanu
    Parrish, Nicole M.
    Nuermberger, Eric L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (03)
  • [44] Characterization of broad-spectrum Mycobacterium abscessus class A β-lactamase
    Soroka, Daria
    Dubee, Vincent
    Soulier-Escrihuela, Olivia
    Cuinet, Guillaume
    Hugonnet, Jean-Emmanuel
    Gutmann, Laurent
    Mainardi, Jean-Luc
    Arthur, Michel
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (03) : 691 - 696
  • [45] In vitro and intracellular activity of vaborbactam combined with β-lactams against Mycobacterium abscessus
    Sanchez, Lea
    Bitar, Maria
    Herail, Quentin
    Dorchene, Delphine
    Hugonnet, Jean-Emmanuel
    Arthur, Michel
    Mainardi, Jean-Luc
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (08) : 1914 - 1918
  • [46] THIACETAZONE - INVITRO ACTIVITY AGAINST MYCOBACTERIUM-AVIUM AND MYCOBACTERIUM-TUBERCULOSIS
    HEIFETS, LB
    LINDHOLMLEVY, PJ
    FLORY, M
    TUBERCLE, 1990, 71 (04): : 287 - 291
  • [47] In Vitro Activity of 3-Triazeneindoles against Mycobacterium tuberculosis and Mycobacterium avium
    Nikonenko, Boris V.
    Kornienko, Albert
    Majorov, Konstantin
    Ivanov, Pavel
    Kondratieva, Tatiana
    Korotetskaya, Maria
    Apt, Alexander S.
    Salina, Elena
    Velezheva, Valeriya
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (10) : 6422 - 6424
  • [48] Activity of Tricyclic Pyrrolopyrimidine Gyrase B Inhibitor against Mycobacterium abscessus
    Madani, Abdeldjalil
    Negatu, Dereje A.
    El Marrouni, Abdellatif
    Miller, Randy R.
    Boyce, Christopher W.
    Murgolo, Nicholas
    Bungard, Christopher J.
    Zimmerman, Matthew D.
    Dartois, Veronique
    Gengenbacher, Martin
    Olsen, David B.
    Dick, Thomas
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (09)
  • [49] In-vitro Activity of Seven Hospital Biocides Against Mycobacterium abscessus
    Caskey, S.
    Moore, J. E.
    Rendall, J. C.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 : S475 - S476
  • [50] IN-VITRO ACTIVITY OF SEVEN HOSPITAL BIOCIDES AGAINST MYCOBACTERIUM ABSCESSUS
    Caskey, S.
    Moore, J. E.
    Rendall, J. C.
    THORAX, 2016, 71 : A134 - A134
12345